Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Building the National Program of Inherited Bleeding Disorders in Brazil.

Rezende SM, Jardim LL, Lúcia Magalhães V, Teixeira Melo H, Araujo JPB, Genovez G.

Blood Adv. 2019 Dec 6;3(Suppl 1):48-50. doi: 10.1182/bloodadvances.2019GS121559. No abstract available.

PMID:
31809542
2.

Standardization and evaluation of the performance of the thrombin generation test under hypo- and hypercoagulability conditions.

Duarte RCF, Rios DRA, Rezende SM, Jardim LL, Ferreira CN, Carvalho MDG.

Hematol Transfus Cell Ther. 2019 Jul - Sep;41(3):244-252. doi: 10.1016/j.htct.2018.08.007. Epub 2018 Dec 31.

3.

Mortality of patients with haemophilia in Brazil: First report.

Jardim LL, van der Bom JG, Caram-Deelder C, Gouw SC, Leal Cherchiglia M, Meireles Rezende S.

Haemophilia. 2019 May;25(3):e146-e152. doi: 10.1111/hae.13730. Epub 2019 Mar 15.

PMID:
30875453
4.

Variation of rs3754689 at lactase gene and inhibitors in admixed Brazilian patients with hemophilia A.

Zuccherato LW, Elói-Santos SM, Jardim LL, Camelo RM, Chaves DG, Souza RP, Hollox EJ, Rezende SM.

Haematologica. 2019 Nov;104(11):e527-e529. doi: 10.3324/haematol.2019.220608. Epub 2019 Mar 14. No abstract available.

5.

Inhibitor incidence in haemophilia A under exclusive use of a third-generation recombinant factor VIII concentrate: results of the HEMFIL Cohort Study.

Jardim LL, van der Bom J, Brommonschenkel CC, Gouw SC, Rezende SM; on the behalf of the HEMFIL Study Group.

Br J Haematol. 2019 Jul;186(1):152-155. doi: 10.1111/bjh.15728. Epub 2018 Dec 17. No abstract available.

PMID:
30556277
6.

Successful immune tolerance in a young female with inhibitor and severe haemophilia A due to a complex genetic rearrangement.

Zuccherato LW, Roberti MRF, Jardim LL, Rezende SM.

Haemophilia. 2018 Jul;24(4):e283-e285. doi: 10.1111/hae.13560. Epub 2018 Jul 13. No abstract available.

PMID:
30004160
7.

Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study.

Jardim LL, Chaves DG, Silveira-Cassette ACO, Simões E Silva AC, Santana MP, Cerqueira MH, Prezotti A, Lorenzato C, Franco V, van der Bom JG, Rezende SM.

Br J Haematol. 2017 Sep;178(6):971-978. doi: 10.1111/bjh.14799. Epub 2017 Aug 23.

PMID:
28836262
8.

Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?

Jardim LL, Rios DR, Perucci LO, de Sousa LP, Gomes KB, Dusse LM.

Clin Chim Acta. 2015 Jul 20;447:34-8. doi: 10.1016/j.cca.2015.05.004. Epub 2015 May 13. Review.

PMID:
25982781
9.

The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort.

Rabelo FY, Jardim LL, Landau MB, Gadelha T, Corrêa MF, Pereira IF, Rezende SM.

Haemophilia. 2015 Sep;21(5):670-80. doi: 10.1111/hae.12645. Epub 2015 Mar 31.

PMID:
25828579
10.

Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia.

Alpoim PN, Gomes KB, Pinheiro Mde B, Godoi LC, Jardim LL, Muniz LG, Sandrim VC, Fernandes AP, Dusse LM.

Nitric Oxide. 2014 Nov 15;42:19-23. doi: 10.1016/j.niox.2014.07.006. Epub 2014 Aug 11.

PMID:
25106888

Supplemental Content

Loading ...
Support Center